Hong Kong
Shoucheng Holdings buys back 20.65M shares
Confident in short-term valuations due to potential returns in robotics and medical technology.
HSBC’s profits down 30.6% to $11.51b in H1 2025
Revenue declined by 9% to $34.1b during the six-month period.
KN Group expands Hong Kong International Business Headquarters
The strategic enterprise is driving corporate globalisation and economic innovation.
Task group evaluates proposals for third medical school
Expert advisors initiated the next phase of work.
Hang Seng Bank’s credit risks rise, but capital buffers remain strong
Credit losses rose to HK$4.86b in H1 versus HK$1.5b a year earlier.
Economy grows by 3.1% in Q2
On a seasonally adjusted quarter-to-quarter basis, real GDP rose by 0.4%.
Retail sales inch up 0.7% YoY in June
Of the total sales value, online sales accounted for 8.5% at $2.b.
6 in 10 organisations still unfamiliar with carbon neutrality: report
78% of enterprises have not yet established comprehensive carbon neutrality targets.
Hong Kong Grade A offices see 44,200 sq ft uptake in June
The increase in take-up was largely driven by financial institutions, which remained active in the leasing market.
FEHD to auction 474 stalls in 43 public markets
Leasing period will be a three-year fixed term beginning 1 September, with no renewal upon expiry.
Hong Kong to achieve new economic breakthroughs: FS Chan
The city is restoring from pandemic and keep attracting talents.
Towngas and CIMC ENRIC jointly develop green methanol and hydrogen energy
Corporation promotes carbon neutrality goal.
Hang Seng Bank launches HK$3b share buy-back programme
Merill Lynch International is appointed as the broker.
Hang Seng Bank’s profits down 30% to HK$6.88b in H1 2025
Fees and other income rose 34% during the period.
HKIA issues guidance on intermediary pay for long-term policies
The HKIA expects insurers to ensure intermediaries provide both pre-contract advice.
Mox Bank enters insurance with QBE tie-up in Hong Kong
The first offering is “Personal Accident Cushion,” a general insurance product.
Read Here
Advertise
Sign Up
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation
Hong Kong should build the Asia–Latin America investment corridor